Edition:
India

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

85.26USD
23 May 2018
Change (% chg)

$0.29 (+0.34%)
Prev Close
$84.97
Open
$84.54
Day's High
$86.16
Day's Low
$84.51
Volume
1,096,365
Avg. Vol
1,343,385
52-wk High
$89.71
52-wk Low
$76.42

Select another date:

Mon, May 7 2018

BRIEF-Mike Weinstein To Join Medtronic As Senior Vice President Of Strategy

* MIKE WEINSTEIN TO JOIN MEDTRONIC AS SENIOR VICE PRESIDENT OF STRATEGY Source text for Eikon: Further company coverage:

BRIEF-UK's CMA says Revoked Initial Enforcement Order On Completed Acquisition By Medtronic Of Animas Corp Assets

* UK'S CMA - HAS REVOKED INITIAL ENFORCEMENT ORDER MADE ON FEB 19 IN RELATION TO COMPLETED ACQUISITION BY MEDTRONIC PLC OF CERTAIN ASSETS OF ANIMAS CORP Source text (http://bit.ly/2jqGZ9X) Further company coverage:

BRIEF-Medtronic Announces New Paid Family Care Leave Benefits

* MEDTRONIC - EXPANDED PAID FAMILY LEAVE BENEFITS; ALL FULL-TIME, PART-TIME U.S. EMPLOYEES TO BE COVERED UNDER MEDTRONIC FAMILY CARE LEAVE POLICY Source text for Eikon: Further company coverage:

BRIEF-Medtronic Receives FDA Approval For Deep Brain Stimulation Therapy For Type Of Epilepsy

* MEDTRONIC RECEIVES FDA APPROVAL FOR DEEP BRAIN STIMULATION THERAPY FOR MEDICALLY REFRACTORY EPILEPSY

BRIEF-Medtronic Announces FDA Approval Of Infuse Bone Graft In New Spine Surgery Indications

* MEDTRONIC ANNOUNCES FDA APPROVAL OF INFUSE(TM) BONE GRAFT IN NEW SPINE SURGERY INDICATIONS USING PEEK INTERBODY IMPLANTS Source text for Eikon: Further company coverage:

UPDATE 2-Edward Lifesciences' heart valve sales in Europe disappoint, shares fall

April 24 Edwards Lifesciences Corp's first-quarter sales for transcatheter heart valves missed Wall Street targets on Tuesday, as the medical device maker lost market share in Europe to its rival, Medtronic Plc.

BRIEF-Medtronic In.Pact Admiral Drug Coated Balloon Receives FDA Approval

* MEDTRONIC IN.PACT(TM) ADMIRAL(TM) DRUG COATED BALLOON RECEIVES FDA APPROVAL TO TREAT LONG SFA LESIONS

BRIEF-Arca Biopharma And Medtronic Extend Gencaro Clinical Trial Collaboration Agreement

* ARCA BIOPHARMA AND MEDTRONIC EXTEND GENCARO CLINICAL TRIAL COLLABORATION AGREEMENT

BRIEF-Medtronic Announces U.S. Launch Of Optisphere Embolization Spheres

* MEDTRONIC - ANNOUNCES U.S. LAUNCH OF OPTISPHERE EMBOLIZATION SPHERES, A RESORBABLE EMBOLIC PLATFORM DESIGNED FOR EMBOLIZATION OF HYPERVASCULAR TUMORS Source text for Eikon: Further company coverage:

BRIEF-Medtronic Expands Visualase MRI-Guided Laser Ablation System to Europe with CE Mark Approval

* MEDTRONIC EXPANDS VISUALASE(TM) MRI-GUIDED LASER ABLATION SYSTEM TO EUROPEAN MARKETS WITH CE MARK APPROVAL

Select another date: